research report: study startup around the world · provides advanced predictive analytics by...

9
Oracle Health Sciences. For life. Study Startup Around the World ChromoReport A quarterly analytical discussion WINTER 2019 Copyright ©2020, Oracle and/or its afliates. All rights reserved.

Upload: others

Post on 08-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Research Report: Study Startup Around the World · provides advanced predictive analytics by leveraging machine-learning capabilities to guide clinical research staf in their daily

Oracle Health Sciences. For life.

Study Startup Around the World ChromoReport A quarterly analytical discussion

WINTER 2019Copyright ©2020, Oracle and/or its affiliates. All rights reserved.

Page 2: Research Report: Study Startup Around the World · provides advanced predictive analytics by leveraging machine-learning capabilities to guide clinical research staf in their daily

ChromoReport | Winter 2019 | Study Startup Around the World

Complexity in clinical trials continues to grow,

a confluence of globalization, outsourcing,

protocol complexities1 and ever-increasing

regulatory mandates. Adding to this dilemma

is the low approval rate of investigational

drugs and growing development costs.2

Introduction

Complexity in clinical trials continues to grow–

a confluence of globalization, outsourcing,

protocol complexities and ever-increasing

regulatory mandates. Adding to this dilemma

is the low approval rate of investigational drugs

and growing development costs. Despite

the nuances between therapeutic areas, the

preliminary step of all clinical trials is study

startup, which is widely recognized as a costly

and perpetual bottleneck.

Study startup is a complex business

involving country selection, pre-

study visits, site selection and

initiation, regulatory document

submission, budget and contract

negotiations, patient recruitment

initiatives, and enrolling the first

patient.

2

Page 3: Research Report: Study Startup Around the World · provides advanced predictive analytics by leveraging machine-learning capabilities to guide clinical research staf in their daily

ChromoReport | Winter 2019 | Study Startup Around the World

Study startup is a journey, and as with any

journey, there are many ways to approach it.

The first question is, how are you going to

navigate? Fifteen years ago, you may have

had no choice but to rely on paper-based

maps and transcribed directions, which might

have turned out to be obsolete or erroneous.

But now, you have web-based maps that are

always up-to-date and supplemented with

satellite images and crowd-sourced, real-time

information. What if you had this kind of

navigation for study startup?

Imagine traveling through multiple

countries, having to navigate

routes with different road rules and

signs in foreign languages, not

aware of potential upcoming traffic

bottlenecks or alternative routes.

3

Page 4: Research Report: Study Startup Around the World · provides advanced predictive analytics by leveraging machine-learning capabilities to guide clinical research staf in their daily

ChromoReport | Winter 2019 | Study Startup Around the World

Determining the start-to-finish (guided directions), optimal route and estimated arrival time is dependent on utilizing a framework that not only

guides sponsors and CROs to compliance using workflows consistent with organizational standards and country-specific regulations, but also

provides advanced predictive analytics by leveraging machine-learning capabilities to guide clinical research staff in their daily activities.

Study Startup Map

ENROLLMENT

ACTIVATION

ACTIVATION SPONSOR INFRASTRUCTURE

ACTIVATION QUALIFICATION

SELECTIONIDENTIFICATION

Study Package Available

Country Quali ed

Ethical Approved

Essential Documentation

Contracted/Indemnity

Site Quali ed

Country Selected

Site ID CDA Signed Selection Selected

System n Infrastructure System 1 Infrastructure

Non–technical Infrastructure Site Infrastructure

All technical Infrastructure

Investigator Meeting

Site Initiation Visit

Country IP Ready

Study/Country Technical Infrastructure

IP Release

Activated/ Enrollment Ready

1

2

Study Enrolled

Enrolled

Not Selected

Counties = Functional areas

Milestones

Destination milestone

Start milestone

Roads = Cycle times

Route

Cities Towns Decision

You must take all routes Fig 1. Study Startup Map, with map terminology overlaid

This framework, or Study Startup Map (Fig 1.) provides a common view, irrespective of specific country/regulatory requirements. It looks

at one aspect cycle times but could easily be extended to include prediction for quality, enrollment, costs, resources and satisfaction/NPS

aspects, as well as, being extensible to include country, study and program levels.

4

Page 5: Research Report: Study Startup Around the World · provides advanced predictive analytics by leveraging machine-learning capabilities to guide clinical research staf in their daily

ChromoReport | Winter 2019 | Study Startup Around the World

Oracle Health Sciences’ in-depth The Journey to Study Startup Optimization

As the industry leader in study startup,

Oracle Health Sciences is well positioned

to standardize across multiple data sets,

to provide a single view of the real-world

metrics and cycle times for study startup

and is working with other industry groups

(e.g., Metrics Champion Consortium, TMF

Reference Model, etc.) to define study

startup milestones.

experience and comprehensive

wealth of standardized metrics

ensures that organizations can

benefit immediately from predictive

capabilities.

5

Page 6: Research Report: Study Startup Around the World · provides advanced predictive analytics by leveraging machine-learning capabilities to guide clinical research staf in their daily

ChromoReport | Winter 2019 | Study Startup Around the World

Navigating Milestones

Based on comprehensive standardized

study startup metrics from machine learning

on over 140,000 sites from sponsors/CROs

studies utilizing the Oracle Health Sciences

Activate Cloud Service, we have identified

the following leading indicators (Fig 2.)

as important to the prediction of the Site

Qualified milestone date.

For example, using these leading

indicators for a Phase III, Oncology,

multi-country study, a USA-based

site is predicated to have a cycle

time of 101 days from Site Package

Sent to Site to Site Qualified. If the

site study package was sent to the

site on November 22, we would

predict that the site would be

qualified for activation by March 2.

6

Page 7: Research Report: Study Startup Around the World · provides advanced predictive analytics by leveraging machine-learning capabilities to guide clinical research staf in their daily

ChromoReport | Winter 2019 | Study Startup Around the World

How does this look for Site Qualification planning? What determines when will we get there? Predictive analytics based on machine learning.

Leading indicators Number of countries 15

Sites in study 141

Sites in country 29

Start month 11

PI in study counts 12

Therapeutic area Oncology

Phase III

Country code USA

IRB/EC type Central

Prediction

Duration (days) 101

Route

ACTIVATION QUALIFICATION

Country Study Package Available Country Quali ed

Ethical Approved

Essential Documentation

Contracted/Indemnity

Site Quali ed

First Ethical Submission

Study Package Available

Site Study Package Available

Study Package Sent to Site

Contract Sent to Site

Country Contract Template

Site Contracting

Selected

+101

22NOV2019 02MAR2020

Counties = Functional areas

Milestones

Destination milestone Roads = Cycle times

Start milestone

Cities Towns Decision You must take all routes

Fig 2. Activation Qualification component of Study Startup Map

7

Page 8: Research Report: Study Startup Around the World · provides advanced predictive analytics by leveraging machine-learning capabilities to guide clinical research staf in their daily

ChromoReport | Winter 2019 | Study Startup Around the World

In Summary

Purpose-built study startup systems that

capture standardized metrics and utilize

advances in data analytics, visualizations,

and prediction have now become an

integral component of decision support

systems. These systems aid compliance

and empower clinical research teams in

improved risk management and proactive

planning practices, providing the best map

for your study startup journey.

Predictive analytics…

• Are a powerful tool for proactive planning of clinical trials and RFP bidding for CROs, which organizations can immediately benefit from with direct

implications on timelines and associated costs.

• Require comprehensive standardized metrics and in-depth experience to ascertain leading indicators for associated aspect/milestone predictions.

• Based on a robust framework and machine learning, can allow prediction for quality, enrollment, costs, resources and satisfaction/NPS aspects, as well as, being extensible to include country, study and program levels.

8

Page 9: Research Report: Study Startup Around the World · provides advanced predictive analytics by leveraging machine-learning capabilities to guide clinical research staf in their daily

ChromoReport | Winter 2019 | Study Startup Around the World

About Oracle Health Sciences

As a  leader in Life Sciences cloud technology, Oracle Health Sciences’  Clinical One and Safety One are  trusted  globally  by professionals in both large and emerging companies engaged in clinical research  and  pharmacovigilance.  With over 20 years’ experience, Oracle Health Sciences is committed to supporting  clinical development, delivering innovation to accelerate advancements, and empowering the Life Sciences industry to improve patient outcomes. Oracle Health Sciences. For life.

Copyright ©2020, Oracle and/or its affiliates. All rights reserved. The preceding is intended to outline our general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, or functionality, and should not be relied upon in making purchasing decisions. The development, release and timing of any features or functionality described for Oracle’s products remains at the sole discretion of Oracle.

C O N TAC T

+1 800 633 0643

[email protected]

www.oracle.com/healthsciences

C O N N E C T

blogs.oracle.com/health-sciences

facebook.com/oraclehealthsciences

twitter.com/oraclehealthsci

linkedin.com/showcase/oracle-health-sciences

9